- Double-blinded, placebo-controlled RCT at two Danish university hospitals, with 100 of 113 randomized patients undergoing non-emergent CABG analyzed.
- Surgeon-administered intraoperative sternal and chest wall infiltration with bupivacaine, epinephrine, clonidine, and dexamethasone (62.5 mL) was compared with saline placebo.
- No difference in opioid use over the first 24 postoperative hours: median 62.3 mg versus 64.0 mg oral morphine equivalents (p = 0.649).
- No secondary or safety endpoints differed significantly, and the authors concluded the intervention did not reduce opioid consumption or add clinical benefit.
Perioperative medicine
Research from anesthesiology, pain and critical care journals, sourced from PubMed.
Sorted by publication date, not import date. Recent filters exclude papers with only a publication year; find those under All years.
AI-generated abstract summaries can contain errors. Verify findings against the original paper before applying them to patient care.
Last successful paper check: 16 Nov 2026 17:18 UTC.
0 newly discovered papers saved; these are not necessarily published today.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
- Single-centre prospective study of 195 patients undergoing cardiac surgery, enrolled between October 2023 and November 2024.
- Patients were grouped into Mild, Moderate, and Severe bleeding clusters using K-Medoids, with cut-offs set on a haemoglobin mass loss per kilogram index.
- The Severe cluster discriminated well (AUC 0.790, 95% CI 0.721-0.859), while chest tube output did not differ significantly between clusters (p = 0.097).
- Haemoglobin mass loss through chest tubes was significant (p = 0.011), and the authors state the index identifies high-risk patients with lower BMI.
- This retrospective national claims study matched 980 patients on GLP-1RAs 1:1 to 980 controls, all with BMI ≥27 kg/m² undergoing nephrectomy for renal neoplasms.
- The exposure was GLP-1RA therapy within 180 days of surgery, compared with matched patients not receiving it, with outcomes assessed at 30 and 90 days.
- GLP-1RA use was associated with lower 90-day AKI (OR 0.76; P = .031), lower MAKE (OR 0.56; P = .004), and lower 30-day readmission (OR 0.72; P = .011).
- The authors conclude that GLP-1RAs may mitigate postoperative risk without increasing gastrointestinal, respiratory, or systemic morbidity.
AI summary not available. Read the source abstract on PubMed.
- Single-center retrospective cohort of 245 adults with HCC who underwent deceased-donor liver transplantation in Australia from 2007 to 2020.
- Compared 167 patients who received intraoperative blood salvage with autotransfusion against 78 who did not, with no leukodepletion filters used.
- Recurrence occurred in 9.0%; unadjusted HR 0.80 (95% CI 0.34–1.92; P = .62) and adjusted HR 0.57 (95% CI 0.23–1.44; P = .24) for time to recurrence.
- The authors concluded salvage was not linked to higher recurrence and supports its safety, while hepatitis C, lesion count, AFP and microvascular invasion predicted recurrence.
- Database study of metformin-treated T2DM patients undergoing primary TKA, split by obesity status and propensity matched 1:1.
- The exposure was GLP-1RA use within three months of surgery, compared with patients not using GLP-1RAs.
- Obesity subgroup: GLP-1RA use was linked to less anemia (OR 0.714; P = 0.001), 90-day readmission (OR 0.776; P = 0.001), and two-year aseptic loosening (OR 0.498; P = 0.037).
- Nonobese patients had lower 90-day readmission (OR 0.514; P = 0.004) and ED visits (OR 0.649; P = 0.024); authors report reduced resource use irrespective of obesity.
- Single-center retrospective cohort of 5537 eligible adults undergoing CABG and/or valve surgery with cardiopulmonary bypass, with TAPSE reported in 1913 and RVFAC in 979.
- Preoperative quantitative right ventricular systolic function, measured by TAPSE and RVFAC, was analyzed against in-hospital mortality, length of stay, and acute kidney injury.
- Lower TAPSE and RVFAC were associated with mortality: TAPSE <17 mm had an OR of 2.15 (95% CI 1.16-4.00) and RVFAC <35% had an OR of 3.66 (95% CI 1.58-8.47).
- Both measures were associated with length of stay but not AKI, and the authors call for better echo reporting to study quantitative RV measures.
AI summary not available. Read the source abstract on PubMed.
- This narrative review synthesizes recent evidence on anesthetic management of giant mediastinal tumors, focusing on the risk of mediastinal mass syndrome.
- It reports that positive pressure ventilation and neuromuscular blockade can be applied safely in selected patients under appropriate monitoring, challenging traditional practice.
- It proposes risk stratification using a tumor size ratio of 0.5 or greater, airway compression above 50%, and hemodynamic parameters.
- It describes ECMO shifting from rescue to prophylactic use and outlines tumor-specific protocols for lysis syndrome, myasthenic crisis, and coagulopathy.
- In 110 children aged 6–16 undergoing elective surgery, normal-weight and overweight/obese groups (55 each) were compared on perioperative respiratory adverse events and lung function.
- Forced oscillation and nitrogen washout were measured sitting and supine before induction, with oscillation repeated after induction, and respiratory symptoms were recorded.
- Minor PRAEs occurred in 34.5% (95% CI, 22.2%–48.6%) of obese children versus 16.4% (95% CI, 7.9%–28.3%) of normal-weight children; severe PRAEs were 5/110 (4.5%), all laryngospasm.
- Obesity raised peripheral airway resistance, and anesthesia-induced bronchodilation was blunted in obese children and those with respiratory symptoms; supine position reduced functional residual capacity.
- Retrospective review of a prospectively maintained cardiac surgery database covering nonemergent isolated CABG patients from 2010 to 2024, with 4170 having complete medication data.
- Preoperative GLP-1 users (165 patients, 3.9%) were compared with nonusers using multivariable Cox models for all-cause mortality, MACCE, and 30-day mortality.
- After adjustment, no significant difference in all-cause mortality or MACCE was found between the groups.
- GLP-1 use was associated with less new-onset postoperative atrial fibrillation (14% vs 22%; P = .02), which the authors say warrants further study.
- Open-label randomised controlled trial of 148 osteosynthesis patients at a university hospital, comparing a thermal care bundle with control.
- The bundle combined 10-minute prewarming, forced-air warming during and after surgery, a room kept at 21 °C, and fluids warmed to 38 °C.
- At surgery start, hypothermia occurred in 1.3% vs 9.9% of controls (OR 7.59, P=0.021), and at PACU admission in 14.3% vs 29.6% (OR 2.07, P=0.024).
- Wound infections requiring readmission were not significantly reduced (OR 0.35, 95% CI 0.04 to 2.92, P=0.332); presurgery stay and OR/PACU occupancy were SSI risk factors.
- Systematic review and meta-analysis of 21 studies including 5725 surgical patients aged 18 or older, with 11 non-cardiac and 10 cardiac surgery studies, searched to March 2024.
- Pooled preoperative prevalence of impairment was compared across six cognitive domains, and perioperative changes in those domains were examined.
- Preoperative impairment was highest in executive function at 18% (95% CI, 13%-24%), followed by visuospatial function at 16% and attention/working memory/processing speed at 14%.
- Postoperative impairment peaked at 1 week (attention 35%, 95% CI 4%-66%) and fell by 3 months, with some confidence intervals crossing zero.
- Systematic review and meta-analysis of 9 randomized controlled trials with 672 patients undertaking VATS, drawn from 31 identified studies.
- Intravenous lidocaine was compared with control, with bolus and infusion regimens varying across trials.
- Lidocaine did not reduce 24-hour (5 trials, n = 328) or 48-hour (3 trials, n = 242) postoperative morphine use, or pooled movement pain scores.
- Lidocaine significantly reduced postoperative nausea and vomiting across 5 trials (n = 360) with negligible heterogeneity, and the authors judged it safe.
- This retrospective TriNetX cohort propensity-matched transgender and cisgender patients undergoing hysterectomy, orchiectomy, or augmentation mammoplasty.
- The exposure was gender-affirming hormone therapy, and the primary outcome was rescue antiemetic use on the day of or the day after surgery.
- Transgender females on estrogen used rescue antiemetics more often than cisgender controls after orchiectomy (51.15% vs 36.78%, P < .0001) and augmentation mammoplasty (53.29% vs 43.71%, P = .0005).
- Transgender males on testosterone used rescue antiemetics less often than cisgender females after hysterectomy (62.11% vs 65.90%, P = .0227), and the authors call for prospective studies.
- Retrospective TriNetX cohort of patients with type 2 diabetes undergoing ACDF, comparing 608 single-level and 639 multi-level GLP-1RA users with propensity-matched nonusers.
- Exposure was perioperative GLP-1 receptor agonist prescription, defined as prescriptions within 6 months before and after surgery, versus no GLP-1RA use.
- Single-level users had lower revision odds at 90 days (OR 0.445, P=0.032) and 6 months (OR 0.489, P=0.034), and pseudarthrosis risk was lower across timepoints.
- Cox regression linked GLP-1RA use to less pseudarthrosis at 1 year (HR 0.665, 95% CI 0.570-0.775, P=0.005), with authors reporting no increase in adverse events.
- This is a review of perioperative neurocognitive disorders, mainly postoperative delirium and postoperative cognitive dysfunction, in elderly cardiac surgery patients.
- It covers proposed mechanisms (neuroinflammation, cerebral hypoperfusion, neurodegeneration), major risk factors, and biomarkers from peripheral blood to neuroimaging.
- Prevention approaches discussed include preoperative cognitive assessment, intraoperative cerebral oxygenation monitoring, and postoperative multimodal analgesia, described as showing promise.
- The authors conclude that the pathophysiology remains incompletely understood and highlight knowledge gaps and directions for future research.
- Ancillary analysis of a randomised trial of 66 adults undergoing cardiac surgery with expected prolonged cardiopulmonary bypass (over 90 min) at one French hospital.
- Patients were randomised to intra-operative haemo-adsorption or standard care, with endotoxin mass and activity measured from pre-surgery to 48 hours after surgery.
- Endotoxin mass fell after bypass while relative endotoxin activity rose, and high postoperative activity was linked to dobutamine requirement, inflammatory markers and organ injury; no effect sizes are reported in the abstract.
- The authors conclude that the capacity to inactivate endotoxin, rather than its quantity, may determine harm, and haemo-adsorption did not lower endotoxin mass or activity.
- Systematic review and meta-analysis of 16 randomized controlled trials including 1133 patients undergoing cardiac surgery with cardiopulmonary bypass.
- Compared intraoperative hemoadsorption using sorbent devices during bypass with bypass conducted without hemoadsorption.
- Hemoadsorption significantly reduced acute kidney injury incidence (RR 0.75; 95% CI 0.59-0.96; p = 0.020).
- Renal replacement therapy, mortality and secondary outcomes showed no significant differences, and the authors call for studies on clinical relevance and patient selection.
- Systematic review and meta-analysis of 19 studies (n = 11,667) of older adults undergoing major cardiac procedures, across four continents.
- Preoperative frailty, identified with validated tools such as the Fried phenotype or Clinical Frailty Scale, was compared with postoperative outcomes; overall prevalence was 16.8%.
- Frailty was associated with delirium (OR 4.11; 95% CI 2.00-8.45), infection (OR 3.72; 95% CI 2.27-6.12), and renal complications (OR 2.72; 95% CI 2.05-3.60), all P <.001.
- Frailty was also linked to longer hospital and ICU stays and to 30-day (OR 3.58) and 1-year (OR 2.25) mortality; the authors suggest routine frailty screening.
- Systematic review and meta-regression of 99 randomized trials (n = 8222) in adults undergoing major elective surgery.
- Pooled exercise prehabilitation against control across procedures, participants, and programs, with prespecified effect modifiers examined.
- Prehabilitation was associated with fewer complications (OR 0.54; 95% CI 0.44-0.67; moderate certainty) and shorter stay (MD -0.90 days; 95% CI -1.23 to -0.58; low certainty).
- Inspiratory muscle training was the only significant effect modifier for both outcomes, at low certainty, and the authors call for individual participant data to clarify factors.
- This retrospective study of 836 adults undergoing cardiac surgery with cardiopulmonary bypass tested whether the fibrinogen/albumin ratio improves major morbidity prediction.
- The fibrinogen/albumin ratio was compared with EuroSCORE II-based models, with and without the ratio added, for predicting major morbidity.
- The ratio was univariately associated with major morbidity (OR 1.025, reported 95% CI 1.061-1.091, P = .004) but had poor discrimination (AUC 0.606).
- The EuroSCORE II model alone had AUC 0.731, and adding the ratio did not improve it (0.730), so the authors found no added value.
- This claims database analysis of 2,361,402 THA and TKA patients in the US (2006 to 2022) examined hospital costs by postoperative complication.
- Major complications were assessed individually and in clusters, and costs were compared using generalized estimating equation models.
- In TKA, adjusted cost increases were largest with three or more complications (+136%), sepsis (+88%), and myocardial infarction (+73%), against a median of $16,802 without complications.
- Frequent complications, including renal failure (+26%), pulmonary complications (+23%), and ICU admission (+61%), were the main drivers of overall cost, largely through longer length of stay.
- Single-center RCT of 140 adults undergoing on-pump cardiac surgery, randomized 1:1 to flow-controlled or pressure-controlled ventilation.
- Individualized FCV with compliance-guided PEEP and driving pressure was compared with PCV using the same compliance-guided settings and tidal volumes of 6 to 8 ml/kg predicted body weight.
- Postoperative IL-8 at 6 h after bypass did not differ significantly (3.08 vs 3.60 pg/ml; β 0.08; 95% CI -0.17 to 0.33; P = 0.573), while mechanical power fell by 55% with FCV.
- Pulmonary and extrapulmonary complications were lower and hospital stay shorter with FCV, but these were explorative secondary outcomes that the authors say justify future trials.
AI summary not available. Read the source abstract on PubMed.
- Retrospective TriNetX database study of 24,645 panniculectomy patients from 150 organizations (2020–2025), comparing prior GLP-1 RA users (n = 6,060) with prior bariatric surgery patients (n = 4,142).
- Propensity matching on age, sex, race, HbA1c, BMI, and triglycerides was used to compare postoperative complications between the two exposure groups.
- GLP-1 RA users had lower odds of cellulitis (OR 0.62, 95% CI 0.47 to 0.83; P = 0.0015), seroma (OR 0.77, 95% CI 0.59 to 0.89; P = 0.026), and hemorrhage (OR 0.51, 95% CI 0.30 to 0.89; P = 0.016).
- The authors conclude that patients who lose weight with GLP-1 RAs may have fewer complications after panniculectomy than those who had bariatric surgery, and they note the GLP-1 RA group had higher BMI, HbA1c, and LDL.
- This before-and-after cohort compared 155 scoliosis surgery patients admitted after implementing a remote monitoring service with 133 admitted before.
- The 24-hour remote continuous monitoring service (HIVE) allowed high-risk patients to be monitored on general wards rather than in ICU or HDU.
- After adjustment, the post-implementation period avoided 27.1 ICU hours and reduced overall costs by AU$2682 (US$2164) per patient.
- The authors concluded the service reduced costs and ICU hours, with no significant differences in length of stay, emergency readmissions, or hospital-acquired complications.
- Observational configurational analysis of 86 hospitals in a national surgical collaborative, using coincidence analysis to model ERP implementation.
- Success was defined as being in the top 25% of hospitals for improvement in ERP adherence over time, with explanatory conditions covering implementation resources, organizational readiness, and hospital characteristics.
- Of 86 hospitals, 26 (30.2%) succeeded, and three scenarios together explained success in over 70% of hospitals (PA consistency=0.719, PA contrapositive coverage=0.752).
- The authors conclude that success varied by local context and depended on organizational readiness, strong staff buy-in, appropriate workload, and sufficient time.
- Retrospective single-center study of 1539 patients with acute appendicitis at Saint Antoine Hospital from 2013 to 2020, excluding abscess and peritonitis.
- Postoperative antibiotics were given to 18.1% of patients, and 57.2% had intra-abdominal fluid, which was compared with patients without fluid.
- Antibiotics did not significantly prevent infection, and infection rates did not differ significantly by intra-abdominal fluid status.
- Independent infection risk factors were ASA score (HR 5.129, P = 0.004), symptoms over 2 days (HR 2.290, P = 0.029), and appendicolith (HR 2.204, P = 0.042).
- In a rat study, thoracotomy with intercostal incision and rib retraction produced mechanical hypersensitivity lasting at least 5 weeks, with the abstract giving no sample size.
- Intrathecal resolvin D1 (30 ng/30 μL) or D2 was given either at surgery or 4 days later, and the abstract does not name the comparator.
- Resolvin D1 halved the spread of the mechanosensitive area and lowered by 60% the proportion of rats with tactile hypersensitivity, while D2's effect on threshold was statistically the same.
- The authors conclude that intrathecal resolvins, given preoperatively or several days after surgery, may prevent chronic postoperative hyperalgesia in rats.
- In this prospective study of 55 patients undergoing cardiac surgery, frailty was measured before surgery and postoperative delirium was identified by validated chart review.
- Frailty was present in 30.9% of patients, and frail patients had delirium in 47.1% versus 2.6% of nonfrail patients (P < 0.001).
- In multivariable models, the relative risk of delirium was 18.3 for frail versus nonfrail patients (95% CI 2.1-161.8; P = 0.009), though the text also cites '≥2.1-fold'.
- The authors suggest frailty could flag patients with higher baseline delirium risk who might benefit from prevention strategies.
- Prospective cohort of 400 adult patients emerging from general anaesthesia, with delirium signs assessed by CAM-ICU at PACU admission, 30 min, 1 h and discharge.
- Signs were classified as hyperactive or hypoactive using CAM-ICU combined with RASS scores; agitated emergence was recorded in the operating room using RASS.
- Delirium signs were present in 31% at PACU admission, falling to 15% at 30 min, 8% at 1 h and 4% at discharge; hypoactive signs made up 92% of cases during PACU stay.
- Perioperative opioids were associated with delirium signs during PACU stay (P=0.02), and the authors suggest structured PACU delirium monitoring.
- Prospective observational study of 491 patients undergoing cardiac surgery with cardiopulmonary bypass, with cerebral autoregulation monitored by the cerebral oximetry index.
- Exposure was the magnitude and duration of mean arterial pressure above the upper autoregulation limit during bypass, assessed against postoperative delirium.
- Delirium occurred in 45 patients (9.2%), and the magnitude-by-duration product of pressure above the limit was independently associated with it (OR 1.09, 95% CI 1.03-1.15).
- Authors suggest keeping MAP within the autoregulation range might reduce delirium; ventilation over 48 h, antidepressant use, and prior stroke were also independently associated.
- Mixed-methods study in two Baltimore ICUs (cardiac surgical and surgical), combining 52 observed patient encounters, provider surveys, and chart review.
- No intervention was tested; the authors compared prescribers with bedside nurses on their views of the ideal pretransfusion hemoglobin and on actual practice.
- Prescribers in both units (87% and 90%) more often than nurses (8% and 42%) named 7 g/dL or lower as ideal for nonbleeding patients (p = 0.002 and 0.015).
- The authors concluded that knowledge gaps, overly optimistic views of current practice, and variable thresholds between prescribers are barriers, and that targeted interventions are needed.
- This is a proposal-style piece, not a full study, and it reports a preliminary pilot analysis in cardiovascular surgery without giving sample size.
- The authors argue that nonlinear fluctuations in hemodynamic variables, including blood pressure, may carry information for intraoperative risk assessment.
- They describe the pilot data only as supporting feasibility and potential merit, and report no effect sizes, confidence intervals, or p values.
- This is an expert group report from a BJA Salzburg Seminar that reviewed animal and human evidence on anaesthetic neurotoxicity; it reports no original sample or quantitative results.
- The topic is general anaesthesia exposure and its possible effects on cognition at both extremes of age, namely young developing brains and the elderly.
- The group concluded that preclinical studies show general anaesthetics strongly modulate neuronal development and function, but definitive clinical data remain lacking.
- The authors argue that because anaesthesia often cannot be avoided, evidence-based strategies to limit potential brain injury are needed.
- Prospective diagnostic study of 91 patients ≥70 years in the PACU and 58 admitted patients (166 ward assessments) after surgery under general anaesthesia.
- CAM-ICU and NuDESC (thresholds ≥2 and ≥1) were compared against a DSM-IV-based neuropsychiatric examination, in the PACU and on daily ward assessments.
- Sensitivity was low for CAM-ICU (28%, 95% CI 16-45%, PACU) and NuDESC ≥2 (32%, 19-48%, PACU), though both had specificity above 90%.
- NuDESC ≥1 raised sensitivity to 80% (65-91%) in the PACU but lowered specificity to 69% (54-80%), and the authors conclude neither tool is adequately sensitive.
- Systematic review and meta-analysis of studies on falls after major lower-limb orthopaedic surgery with peripheral nerve blockade, including 10 studies with 4014 patients for the falls outcome.
- Five studies (four RCTs, one cohort) compared continuous lumbar plexus blockade in 631 patients with non-continuous or no blockade in 964 patients.
- Continuous lumbar plexus blockade was associated with more falls (14 vs 5 events; Peto OR 3.85, 95% CI 1.52 to 9.72, P=0.005, I²=0%), with attributable risk 1.7% and NNH 59.
- The authors concluded that continuous lumbar plexus blockade increases postoperative fall risk, but the attributable risk was within the expected probability of falls after orthopaedic surgery.
- This quality-improvement benchmarking cohort included 11,633 elective colorectal and bariatric patients from 47 Washington hospitals between 2005 and 2010.
- The exposure was perioperative glucose above 180 mg/dL, and insulin administration was compared among hyperglycemic patients.
- Hyperglycemia was linked to higher odds of infection (OR 2.0; 95% CI 1.63-2.44), reoperation (OR 1.8; 95% CI 1.41-2.3), and death (OR 2.71; 95% CI 1.72-4.28).
- Hyperglycemic patients who received day-of-surgery insulin showed no significant increase in these outcomes, and risk rose with worse insulin-related glucose control.
- This is a narrative review, not a primary study, and it reports no sample size or patient outcomes.
- It examines how genetic variation in the adrenergic signaling pathway and in the CYP2D6 enzyme may alter β-blocker efficacy and toxicity around perioperative myocardial infarction.
- The authors argue that interindividual genetic differences are largely absent from current debate on β-blocker use, which has become controversial in this setting.
- They conclude that these polymorphisms are likely relevant to β-blocker efficacy, safety, and toxicity, but this is a mechanistic argument rather than a tested finding.